Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory

References

• MiravitllesM, DirksenA, FerrarottiI, et al. European respiratory society statement: diagnosis and treatment of pulmonary disease in alpha-1 antitrypsin deficiency. Eur Respir J. 2017;50:1700610. doi:10.1183/13993003.00610-201729191952
   PubMed Web of Science ®Google Scholar
• GreeneCM, MarciniakSJ, TeckmanJ, et al. α1-antitrypsin deficiency. Nat Rev Dis Primers. 2016;16052.27465832
   PubMed Web of Science ®Google Scholar
• LomasDA, FinchJT, SeyamaK, NukiwaT, CarrellRW. Alpha 1-antitrypsin Siiyama (Ser53→Phe). Further evidence for intracellular loop-sheet polymerization. J Biol Chem. 1993;268:15333–15335.8340361
   PubMed Web of Science ®Google Scholar
• LomasDA, ElliottPR, SidharSK, et al. Alpha 1-antitrypsin mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem. 1995;270:16864–16870. doi:10.1074/jbc.270.28.168647622502
   PubMed Web of Science ®Google Scholar
• MiravitllesM, HerrC, FerrarottiI, et al. Laboratory testing of individuals with severe AAT deficiency in three European centres. Eur Respir J. 2010;35:960–968. doi:10.1183/09031936.0006970920436173
   PubMed Web of Science ®Google Scholar
• McElvaneyNG. Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm. Eur Respir Rev. 2015;24:52–57. doi:10.1183/09059180.1001081425726555
   PubMedGoogle Scholar
• BarkerA, BrantlyM, CampbellE, CarrellR, CoxDW, DirksenAE. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997;75(5):397–415.9447774
   PubMed Web of Science ®Google Scholar
• CasasF, BlancoI, MartinezMT, et al. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update. Arch Bronconeumol. 2015;51(4):185–192. doi:10.1016/j.arbres.2014.05.00825027067
   PubMed Web of Science ®Google Scholar
• BlancoI, BuenoP, DiegoI, et al. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update. Int J Chron Obstruct Pulmon Dis. 2017;12:561–569. doi:10.2147/COPD.S12538928243076
   PubMed Web of Science ®Google Scholar
• LaraB, BlancoI, MartínezMT, et al. Spanish registry of patients with alpha-1 antitrypsin deficiency: database evaluation and population analysis. Arch Bronconeumol. 2017;53:13–18. doi:10.1016/j.arbres.2016.05.00327323654
   PubMed Web of Science ®Google Scholar
• StollerJK. Detecting alpha-1 antitrypsin deficiency. Ann Am Thorac Soc. 2013;13(Suppl4):S317–S325. doi:10.1513/AnnalsATS.201506-349KV
   Web of Science ®Google Scholar
• MiravitllesM, MonteagudoM, SolntsevaI, AlcázarB. Blood eosinophil counts and their variability and risk of exacerbations in COPD: a population-based study. Arch Bronconeumol. 2020;12:pii: S0300–2896(19)30623–4. doi:10.1016/j.arbres.2019.12.015
   Web of Science ®Google Scholar
• FerrarottiI, ThunGA, ZorzettoM, et al. Serum levels and genotype distribution of α1-antitrypsin in the general population. Thorax. 2012;67:669–674. doi:10.1136/thoraxjnl-2011-20132122426792
   PubMed Web of Science ®Google Scholar
• ZerimechF, HennacheG, BellonF, et al. Evaluation of a new Sebia isoelectrofocusing kit for alpha 1-antitrypsin phenotyping with the hydrasys system. Clin Chem Lab Med. 2008;46(2):260–263. doi:10.1515/CCLM.2008.03618076352
   PubMed Web of Science ®Google Scholar
• BelmonteI, MontotoL, MiravitllesM, et al. Rapid detection of mmaltonα1-antitrypsin deficiency allele by real-time PCR and melting curves in whole blood, serum and dried blood spot samples. Clin Chem Lab Med. 2016;54:241–248. doi:10.1515/cclm-2015-029726154193
   PubMed Web of Science ®Google Scholar
• BelmonteI, BarrechegurenM, EsquinasC, RodriguezE, MiravitllesM, Rodriguez-FriasF. Genetic diagnosis of alpha1-antitrypsin deficiency using DNA from buccal swab and serum samples. Clin Chem Lab Med. 2017;55(9):1276–1283. doi:10.1515/cclm-2016-084228107169
   PubMed Web of Science ®Google Scholar
• SterlingRK, LissenE, ClumeckN, et al. Development of a simple non-invasive index to predict significant fibrosis patients with HIV/HCV co-infection. Hepatology. 2006;43:1317–1325. doi:10.1002/hep.2117816729309
   PubMed Web of Science ®Google Scholar
• Vallet‐PichardA, MalletV, NalpasB, et al. FIB‐4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32–36. doi:10.1002/hep.2166917567829
   PubMed Web of Science ®Google Scholar
• YongSH, LeemAY, KimYS, et al. Hepatic fibrosis assessed using fibrosis-4 index is predictive of all-cause mortality in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:831–839. doi:10.2147/COPD.S24286332368029
   PubMed Web of Science ®Google Scholar
• StrnadP, McElvaneyNG, LomasDA, LongoDL. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382(15):1443–1455. doi:10.1056/NEJMra191023432268028
   PubMed Web of Science ®Google Scholar
• SorianoJB, LucasSJ, JonesR, et al. Trends of testing for and diagnosis of α1-antitrypsin deficiency in the UK: more testing is needed. Eur Respir J. 2018;52(1):1800360. doi:10.1183/13993003.00360-201829853490
   PubMed Web of Science ®Google Scholar
• BarrechegurenM, MonteagudoM, SimonetP, et al. Diagnosis of alpha-1 antitrypsin deficiency: a population-based study. Int J Chron Obstruct Pulmon Dis. 2016;11:999–1004.27274221
   PubMed Web of Science ®Google Scholar
• BlancoI, de SerresFJ, Fernandez-BustilloE, LaraB, MiravitllesM. Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J. 2006;27:77–84. doi:10.1183/09031936.06.0006230516387939
   PubMed Web of Science ®Google Scholar
• BlancoI, DiegoI, BuenoP, Pérez-HolandaS, Casas-MaldonadoF, MiravitllesM. Prevalence of alpha-1 antitrypsin genotypes in patients with COPD in Europe: a systematic review. Eur Respir Rev. 2020;29:200014. doi:10.1183/16000617.0014-202032699024
   PubMed Web of Science ®Google Scholar
• MeiraL, BoaventuraR, SeixasS, SucenaM. Alpha-1 antitrypsin deficiency detection in a Portuguese population. COPD. 2018;15(1):4–9. doi:10.1080/15412555.2017.141477929393705
   PubMedGoogle Scholar
• GreulichT, OttavianiS, BalsR, et al. Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. Respir Med. 2013;107:1400–1408.23786890
   PubMed Web of Science ®Google Scholar
• TaliercioRM, ChatburnRL, StollerJK. Knowledge of alpha-1 antitrypsin deficiency among internal medicine house officers and respiratory therapists: results of a survey. Respir Care. 2010;55(3):322–327.20196882
   PubMed Web of Science ®Google Scholar
• EsquinasC, BarrechegurenM, SucenaM, RodríguezE, FernandezS, MiravitllesM. Practice and knowledge about diagnosis and treatment of alpha-1 antitrypsin deficiency in Spain and Portugal. BMC Pulm Med. 2016;16:64. doi:10.1186/s12890-016-0222-4
   Web of Science ®Google Scholar
• de la RozaC, Rodriguez-FriasF, LaraB, VidalR, JardiR, MiravitllesM. Results of a case-detection programme for alpha1-antitrypsin deficiency in COPD patients. Eur Respir J. 2005;26:616–622. doi:10.1183/09031936.05.0000730516204591
   PubMed Web of Science ®Google Scholar
• GreulichT, Rodríguez-FriasF, BelmonteI, KlemmerA, VogelmeierCF, MiravitllesM. Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency. Respir Res. 2018;19:151. doi:10.1186/s12931-018-0826-830103740
   PubMed Web of Science ®Google Scholar
• JainA, McCarthyK, XuM, et al. Impact of a clinical decision support system in an electronic health record to enhance detection of alpha 1 antitrypsin deficiency. Chest. 2011;140(1):198–204. doi:10.1378/chest.10-165821193532
   PubMed Web of Science ®Google Scholar
• MolinaJ, FlorX, GarciaR, TimiraosR, Tirado-CondeG, MiravitllesM. The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting. Ther Adv Respir Dis. 2011;5:237–243. doi:10.1177/175346581140491921652608
   PubMedGoogle Scholar
• Rodriguez-FriasF, MiravitllesM, VidalR, CamosS, JardiR. Rare alpha-1-antitrypsin variants: are they really so rare? Ther Adv Respir Dis. 2012;6(2):79–85. doi:10.1177/175346581143432022291048
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJL, Casas-MaldonadoF, Torres-DuranM, et al. Results of a diagnostic procedure based on multiplex technology on dried blood spots and buccal swabs for subjects with suspected alpha1 antitrypsin deficiency. Arch Bronconeumol. 2020;14:S0300–2896(20)30131–9. doi:10.1016/j.arbres.2020.04.014
   Web of Science ®Google Scholar
• BarrechegurenM, Torres-DuranM, Casas-MaldonadoF, MiravitllesM. Spanish implementation of the new international alpha-1 antitrypsin deficiency international registry: the European Alpha-1 Research Collaboration (EARCO). Arch Bronconeumol. 2020;pii:S0300–2896(20)30061–2. doi:10.1016/j.arbres.2020.02.003
   Web of Science ®Google Scholar
• SandersCL, PonteA, KueppersF. The effects of inflammation on alpha 1 antitrypsin levels in a National Screening Cohort. COPD. 2018;15:10–16. doi:10.1080/15412555.2017.140160029381093
   PubMedGoogle Scholar
• JanciauskieneS, DeLucaDS, BarrechegurenM, WelteT, MiravitllesM. Serum levels of alpha1-antitrypsin and their relationship with COPD in the general Spanish population. Arch Bronconeumol. 2020;56:76–83. doi:10.1016/j.arbres.2019.03.00131153743
   PubMed Web of Science ®Google Scholar
• EllisP, TurnerA. What do alpha-1 antitrypsin levels tell us about chronic inflammation in COPD? Arch Bronconeumol. 2020;56(2):72–73. doi:10.1016/j.arbres.2019.06.01031340890
   PubMed Web of Science ®Google Scholar
• KueppersF. PredictAAT: accounting for inflammation in the diagnosis of alpha 1 antitrypsin deficiency. COPD. 2020;1–4. doi:10.1080/15412555.2020.1812055
   Google Scholar